{"transactions":[{"id":731913,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:15:40.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000051","document":"wk-form4_1781813735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000051/wk-form4_1781813735.xml","form_type":"4"}},{"id":1129159,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:37:34.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019044","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019044/rdgdoc.xml","form_type":"4"}},{"id":1453672,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-16T20:39:38.000Z","date":"2024-07-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.8065,"value":68065.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.72 to $6.855, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-24-022829","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924022829/rdgdoc.xml","form_type":"4"}},{"id":1515865,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T01:05:59.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":39200,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001437749-24-017174","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924017174/rdgdoc.xml","form_type":"4"}},{"id":1787006,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-06T20:39:33.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.8764,"value":48764.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.76 to $4.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-23-025312","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923025312/rdgdoc.xml","form_type":"4"}},{"id":1796287,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-08-25T20:19:57.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":58800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, August 7, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer."}],"balance_after":58800,"derivative":{"exercise_price":4.86,"expiration_date":"2033-08-06","underlying":"Common Stock","underlying_shares":58800},"source":{"system":"sec-edgar","filing":"0001437749-23-024680","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923024680/rdgdoc.xml","form_type":"4"}},{"id":4461138,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-08T16:56:55.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The securities awarded on 2/06/2017 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 20,000 shares of common stock shall vest periodically over the next four years upon the Company achieving certain milestones."}],"balance_after":40000,"derivative":{"exercise_price":47.7,"expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-17-000574","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218017000574/primarydocument.xml","form_type":"4"}},{"id":4516604,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-19T16:11:57.000Z","date":"2016-12-15","kind":"exercise","acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option shall vest in full on May 5, 2018, subject to continued service through such date."}],"balance_after":165138,"derivative":{"exercise_price":8.92,"expiration_date":"2024-05-21","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001562180-16-003843","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003843/primarydocument.xml","form_type":"4"}},{"id":4516603,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-12-19T16:11:57.000Z","date":"2016-12-15","kind":"tax_withholding","acquired":false,"shares":346,"price":48.99,"value":16950.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported on this Form 4 were effected pursuant to a stock swap using existing employee stock purchase (espp) shares."}],"balance_after":1554,"source":{"system":"sec-edgar","filing":"0001562180-16-003843","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003843/primarydocument.xml","form_type":"4"}},{"id":4516602,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-12-19T16:11:57.000Z","date":"2016-12-15","kind":"exercise","acquired":true,"shares":1900,"price":8.92,"value":16948.0,"ownership":{"direct":true},"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001562180-16-003843","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003843/primarydocument.xml","form_type":"4"}},{"id":4518366,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-16T16:18:56.000Z","date":"2016-12-08","kind":"grant","acquired":true,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The securities awarded on 1/23/2015 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 4,375 shares of common stock vested on the one year anniversary of the Vesting Start Date with 13,125 shares vesting in 36 equal monthly installments thereafter. Options to purchase 42,000 shares of common stock vest periodically over four years from the grant date upon the company reaching certain milestone requirements, of which the performance criteria were met with the respect of 12,600 shares."}],"balance_after":59500,"derivative":{"exercise_price":38.25,"exercise_date":"2016-12-08","expiration_date":"2025-01-23","underlying":"Common Stock","underlying_shares":12600},"source":{"system":"sec-edgar","filing":"0001562180-16-003829","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003829/primarydocument.xml","form_type":"4"}},{"id":4540824,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-28T16:03:18.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2015 Stock Option and Incentive Plan. The option shall vest in full on May 5, 2018, subject to continued service through such date."}],"balance_after":167038,"derivative":{"exercise_price":8.92,"expiration_date":"2024-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-16-003622","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003622/primarydocument.xml","form_type":"4"}},{"id":4540823,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-11-28T16:03:18.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":10000,"price":55,"value":550000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-16-003622","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003622/primarydocument.xml","form_type":"4"}},{"id":4540822,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-11-28T16:03:18.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":10000,"price":8.92,"value":89200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-16-003622","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218016003622/primarydocument.xml","form_type":"4"}}]}